دورية أكاديمية
أعرض في EDS

Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014-2020.

التفاصيل البيبلوغرافية
العنوان: Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014-2020.
المؤلفون: Prasad N; Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Rhodes J; Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Deng L; Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., McCarthy NL; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Moline HL; Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Baggs J; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Reddy SC; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Jernigan JA; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Havers FP; COVID-19 Emergency Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Sosin DM; New Mexico Emerging Infections Program, New Mexico Department of Health, Santa Fe, New Mexico, USA., Thomas A; Public Health Division, Oregon Health Authority, Portland, Oregon, USA., Lynfield R; Minnesota Department of Health, St. Paul, Minnesota, USA., Schaffner W; Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Reingold A; California Emerging Infections Program, Oakland, California, USA.; Berkeley School of Public Health, University of California, Berkeley, California, USA., Burzlaff K; New York State Department of Health, Albany, New York, USA., Harrison LH; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA., Petit S; Connecticut Department of Public Health, Hartford, Connecticut, USA., Farley MM; Department of Medicine, Emory University School of Medicine and the Atlanta VAMC, Atlanta, Georgia, USA., Herlihy R; Colorado Department of Public Health and the Environment, Denver, Colorado, USA., Nanduri S; Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Pilishvili T; Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., McNamara LA; Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Schrag SJ; Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Fleming-Dutra KE; Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kobayashi M; Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Arvay M; Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
المصدر: The Journal of infectious diseases [J Infect Dis] 2023 Apr 12; Vol. 227 (7), pp. 907-916.
نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Publication: Jan. 2011- : Oxford : Oxford University Press
Original Publication: 1904-2010 : Chicago, IL : University of Chicago Press
مواضيع طبية MeSH: COVID-19*/epidemiology , Bacterial Infections*, United States/epidemiology ; Humans ; Infant ; Incidence ; Pandemics ; Streptococcus pneumoniae ; Haemophilus influenzae ; Streptococcus agalactiae
مستخلص: Background: Descriptions of changes in invasive bacterial disease (IBD) epidemiology during the coronavirus disease 2019 (COVID-19) pandemic in the United States are limited.
Methods: We investigated changes in the incidence of IBD due to Streptococcus pneumoniae, Haemophilus influenzae, group A Streptococcus (GAS), and group B Streptococcus (GBS). We defined the COVID-19 pandemic period as 1 March to 31 December 2020. We compared observed IBD incidences during the pandemic to expected incidences, consistent with January 2014 to February 2020 trends. We conducted secondary analysis of a health care database to assess changes in testing by blood and cerebrospinal fluid (CSF) culture during the pandemic.
Results: Compared with expected incidences, the observed incidences of IBD due to S. pneumoniae, H. influenzae, GAS, and GBS were 58%, 60%, 28%, and 12% lower during the pandemic period of 2020, respectively. Declines from expected incidences corresponded closely with implementation of COVID-19-associated nonpharmaceutical interventions (NPIs). Significant declines were observed across all age and race groups, and surveillance sites for S. pneumoniae and H. influenzae. Blood and CSF culture testing rates during the pandemic were comparable to previous years.
Conclusions: NPIs likely contributed to the decline in IBD incidence in the United States in 2020; observed declines were unlikely to be driven by reductions in testing.
Competing Interests: Presented in part: 12th International Symposium on Pneumococci and Pneumococcal Diseases, Toronto, Canada, 19-23 June.
(Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.)
References: BMC Infect Dis. 2018 Dec 7;18(1):637. (PMID: 30526505)
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. (PMID: 32298251)
Lancet Microbe. 2022 May;3(5):e366-e375. (PMID: 35544097)
MMWR Morb Mortal Wkly Rep. 2021 Jul 23;70(29):1013-1019. (PMID: 34292924)
Nat Rev Microbiol. 2018 Jun;16(6):355-367. (PMID: 29599457)
Front Immunol. 2018 Nov 16;9:2640. (PMID: 30505304)
N Engl J Med. 2011 May 26;364(21):2016-25. (PMID: 21612470)
Nat Hum Behav. 2021 Apr;5(4):529-538. (PMID: 33686204)
Clin Infect Dis. 2021 Mar 1;72(5):e65-e75. (PMID: 33196783)
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. (PMID: 32711058)
Virulence. 2014 Jan 1;5(1):4-11. (PMID: 24335434)
Lancet Digit Health. 2021 Jun;3(6):e360-e370. (PMID: 34045002)
BMC Med Res Methodol. 2021 Mar 22;21(1):58. (PMID: 33752604)
MMWR Morb Mortal Wkly Rep. 2022 Sep 16;71(37):1169-1173. (PMID: 36107787)
Pediatr Infect Dis J. 2021 Aug 1;40(8):e313-e316. (PMID: 34250979)
Clin Infect Dis. 2021 Apr 8;72(7):e184-e191. (PMID: 33150393)
J Infect Dis. 2001 Apr 1;183(7):1138-42. (PMID: 11237844)
Microbiol Spectr. 2019 Mar;7(2):. (PMID: 30900541)
Curr Top Microbiol Immunol. 2014;385:327-56. (PMID: 25027822)
Eur J Clin Microbiol Infect Dis. 1995 Nov;14(11):935-48. (PMID: 8654443)
Am J Transplant. 2020 Dec;20(12):3681-3685. (PMID: 33264506)
معلومات مُعتمدة: CC999999 United States ImCDC Intramural CDC HHS; United States CC CDC HHS
فهرسة مساهمة: Keywords: COVID-19; United States; invasive bacterial disease; nonpharmaceutical intervention
تواريخ الأحداث: Date Created: 20230201 Date Completed: 20230414 Latest Revision: 20240326
رمز التحديث: 20240326
مُعرف محوري في PubMed: PMC10961849
DOI: 10.1093/infdis/jiad028
PMID: 36723871
قاعدة البيانات: MEDLINE
الوصف
تدمد:1537-6613
DOI:10.1093/infdis/jiad028